Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...

Novo Nordisk A/S (NYSE:NVO), the Danish pharmaceutical giant renowned for its weight-loss drug Wegovy and diabetes treatment ...

Related articles EMA says Ozempic, Wegovy may cause rare eye condition Shopify, Citi named signature picks at Wells Fargo Goldman Sachs lowers MYR Group, raises MasTec ...

For many people, Ozempic is a game-changer in the fight against obesity. But while the drug is known for its powerful appetite-suppressing effects, some users are reporting dramatic shifts in how ...

Ozempic and other so-called “miracle” weight-loss meds are being prescribed to teens in record numbers, with prescriptions among 12- to 17-year-olds jumping 50% in 2024, according to Truveta.

Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...

Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide ...

Memory loss might have met its match. A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss — when a drug is prescribed for something it’s not approved for.